stoxline Quote Chart Rank Option Currency Glossary
  
Envoy Medical, Inc. (COCH)
4.91  -0.28 (-5.4%)    04-29 16:00
Open: 5.01
High: 5.26
Volume: 23,732
  
Pre. Close: 5.19
Low: 4.91
Market Cap: 96(M)
Technical analysis
2024-04-29 4:45:01 PM
Short term     
Mid term     
Targets 6-month :  6.86 1-year :  8.4
Resists First :  5.87 Second :  7.19
Pivot price 5.48
Supports First :  3.73 Second :  3.1
MAs MA(5) :  5.05 MA(20) :  5.53
MA(100) :  3.31 MA(250) :  5.93
MACD MACD :  0 Signal :  0.1
%K %D K(14,3) :  14.3 D(3) :  15.5
RSI RSI(14): 47.4
52-week High :  11.72 Low :  0.74
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ COCH ] has closed above bottom band by 25.1%. Bollinger Bands are 30.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 5.27 - 5.29 5.29 - 5.32
Low: 4.85 - 4.88 4.88 - 4.9
Close: 4.86 - 4.91 4.91 - 4.95
Company Description

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices; and Acclaim cochlear implants. Envoy Medical Corporation was formerly known as St. Croix Medical, Inc. and changed its name to Envoy Medical Corporation in December 2004. The company was founded in 1995 and is based in White Bear Lake, Minnesota.

Headline News

Sat, 20 Apr 2024
ROSEN, A LONGSTANDING LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class ... - PR Newswire

Mon, 04 Mar 2024
Envoy Medical Secures $10M to Advance Fully Implanted Cochlear Implant - HIT Consultant

Sun, 03 Mar 2024
Insiders with their considerable ownership were the key benefactors as Envoy Medical, Inc. (NASDAQ:COCH) touches US$122m market cap - Simply Wall St

Sun, 03 Mar 2024
Insiders with their considerable ownership were the key benefactors as Envoy Medical, Inc. (NASDAQ:COCH) touches ... - Yahoo Finance

Thu, 29 Feb 2024
Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket - Markets Insider

Mon, 22 Jan 2024
MCRA Provides Anzu Special Acquisition Corp I with Strategic Diligence Support Leading to Envoy Medical Merger ... - PR Newswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 0 (M)
Shares Float 20 (M)
Held by Insiders 7.16e+006 (%)
Held by Institutions 63.6 (%)
Shares Short 11 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -1.824e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -7 %
Return on Assets (ttm) 89.4 %
Return on Equity (ttm) -225.3 %
Qtrly Rev. Growth 316000 %
Gross Profit (p.s.) 140.97
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth -2.4 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -18 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow -145.12
Stock Dividends
Dividend 0
Forward Dividend 42530
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android